A.D. Vovk, N.V. Tatianko, S.V. Fedorchenko, O.V. Liashok. Employment of alpha2-recombinant interferon in the treatment of patients with acute and chronic hepatitis B. // Medical business.–1998.–V.7.–P. 117-120.
E. Shunko, O. Laksha, L. Krivohatska. Pathogenic substantiation of Laferon therapy in newborn with hepatitis B // Medicines of Ukraine.–2000.–V.7-8.–P. 49-51.
V.M. Mavrodii, A.I. Golovchenko. Modern programs in gastroenterology - into 21 century (methodical recommendations for physicians) // Odessa.–1999.–64 p.
A.B. Volosianko. Time-related changes in indices of humoral immunity and beta2-microglobulin content in children with chronic hepatitis // Medical business.–2000.–V.2.–P. 67-69.
S.A. Kramarev. Modern approaches to virus hepatitis treatment in children // Health of Ukraine.-2003.-V.18 (79).-P.16.
Ye. Neiko, R. Novosiadly. Virological diagnosis and etiotropic therapy of chronic viral hepatitis // Treatment and diagnostics.-2001.-V.3.-P. 28-32.
V.M. Mavrodii. Promising directions in diagnostics and treatment of digestive apparatus diseases // Bulletin of medical rehabilitation and physiotherapy problems. 1996.-V.1, Issue.1.-P.112-115.
Information letter of Health Protection Department of Odessa ’s regional state administration. Standard of diagnostic, treatment of chronic hepatitis and cirrhosis in Odessa region. № 627/02 of 11.05.01 Odessa .
Information letter of Health Protection Department of Odessa ’s regional state administration. Modern diagnostic and treatment of chronic hepatitis, cirrhosis. № 894/02 of 13.08.97 Odessa.

Information letter of Health Protection Department of Odessa ’s regional state administration. Sepsis – difficulties of diagnostic and possibilities of treatment. № 786/02 of 29.05.98 Odessa .

I.G. Kuriata. Clinical evaluation of Laferon therapy effectiveness of herpes zoster // Infection diseases.–1998.–V.3.–P. 54-55.
I.G. Kuriata. Combination treatment of herpes zoster. // Bulletin of scientific research.–1999.–V.2.– P. 74-76.
I.O. Petrenko. Clinical and immunological efficiency of interferon alpha and amizone in complex therapy of ophthalmic herpes. // Ukrainian chemotherapeutic journal.-2001.-V.1.-P.46-47.
N.N. Tkachuk, L.V. Struk, L.V. Ischenko.  Laferon application in complex treatment of herpetic stomatitis // Materials of IV international conference maxillofacial surgeons and stomatologist.–Saint Petersburg.–1999.–P.143.
S. Nedashkivska, I. Dzublik, O. Trohimenko et al. Experimental substantiation of Laferon and enterosgel composition (extemporal production) action effectiveness in herpetic infection. // Medicines of Ukraine.-2001.-V.9.-P.37-40.
V.E. Kazmirchuk, M.I. Miroshnikova. Treatment of complicated Epstein-Barr viral infections // Modern infections.-2002.-V.4.-P. 12-19.
I.S. Markov. Combined therapy of chronic recurrent herpetic (HSV) infection // Woman’s health.-2001.-3 (7).-P. 57-66.
N.S. Neshkov. Problems in diagnostic and treatment of genital herpes // Health of Ukraine.-2002.-V.12.-P.3.

A.A. Rudenko. Modern methods in chemotherapy of acute respiratory diseases // Bulletin of pharmacology.–1999.–V.6.–P. 42-44.
A.A. Rudenko. Immunological aspects, pathogenesis, diagnostic and treatment of influenza and ARD // Journal of general practitioner.-1999.-V.6.-P.2-4.
A.A. Rudenko, V.V. Konenko, N.V. Okruzhnov, Z.P. Sidorova. Modern foundations of chemoprophylaxis and chemotherapy of influenza and other ARD //Journal of general practitioner.-1998.-V.5.-P.42-44
I.V. DzybliK. Modern antiviral drugs. // Bulletin of pharmacology. -1998.-V.2.-P.49-53.
V.V. Kononenko. Clinical diagnostic and treatment of central nervous system implications in influenza //Journal of general practitioner.-1998.-V.5.-P.14-17.
Information letter of Health Protection Department of Odessa ’s regional state administration. Optimal chemotherapy of acute pneumonia. № 1106/02 of 29.09.97 to execution of order of MHU № 91 of 26.08.93 Odessa .
V.P. Vinogradov, A.T. Slabospickaia, V.A. Kordyum. Laferon in clinic of newborns // Materials of research and practical conference. “Laferon in treatment of infection and oncologic diseases”.– Rovno.–1996.–P. 24-31.

A.A. Rudenko, L.V. Muravskaya, Ye.K. Trinus et al. Laferon in treatment of meningocephalitis // Medical business.–1995.–V.3-4.–P. 109-112.
Diagnostic and treatment of viral meningocephalitis (methodical recommendations) // Kiev.-1995.
V.V. Kononenko. Clinical diagnostic and treatment of central nervous system implications in influenza //Journal of general practitioner.-1998.-V.5.-P.14-17.

L.S.Bondarev. Enterovirus infection (Clinical manifestation, laboratory diagnostics, therapy). // Treatment and diagnostics.-2001.-V.2.-P.46-50.

V.P. Lacatosh, L.M. Lazarenko, L.O. Lanenko et al. Mathematical modeling and predicting of treatment effectiveness in cervix of the uterus papilloma infection // Medical business.–2000.–V.5.–P. 65-71.
T.Ye. Tkachuk. Treatment of dystrophy, displasia and valvular carcinoma in virus infection // Medical business.–2002.–V.1.–P. 80-84.
I.M. Ivanova, V.D. Lischuk, L.I. Isakova. Complex therapy of subclinical manifestation papilloma virus infection in women with cervix of the uterus pathology // Journal of obstetrics and women illnesses. Special edition.-1998.-P.-50.

S.I. Korovin. Recombinant alpha-2b interferon in the adjuvant therapy of patients with skin melanoma // Medical business.–1998.–V.2.–P. 139-141.
S.I. Korovin. Endolymphatic therapy in treatment of primary-limited skin melanoblastoma // Clinical surgery.–1998.–V.1.–P. 39-40.
S.I. Korovin, B.A. Tolstopyatov, Yu.R. Medinets et.al. The experience gained with the use of local magnetothermia in treating patients with primary-confined melanoma of the skin // Medical business.–2002.–V.1.–P. 129-133.
L.N. Velichko, V.V.Vit, A.P. Maletsiy, E.I. Dragomiretska. Immunocorrection with alpha-2b interferon as important component in therapy of uveal melanoma. // Oncology.–2000.–V.2, Issue 1-2.–P. 64-67.
L.N. Velichko, T.V. Degtyarenko, A.P. Maletsky. Changes in phagocytic activity of monocytes/macrophages in patients with melanoma in a complex treatment including laferon // Ophthalmologic journal.-1997.-V.5.-P.348-351.
L.N. Velichko, V.V. Vit, A.P. Maletsky. The transformation of monocytes into macrophages in autologic serum of patients with melanoma of the uveal tract of the eye in the process of organ-preserving therapy and laferon usage // Ophthalmologic journal.-1997.-V.1.-P.39-41.
A.F. Vozianov, K.P. Zak, V.V. Afanasyeva, M.A. Grusov et.al. Immunologic phenotype of lymphocytes and ultrastructure of leucocytes in the blood of patients with metastatic renal cell carcinoma treated with recombinant interferon alpha-2b and fluorouracil // Experimental oncology.–1998.–V.20, Issue 1.–P. 53-59.
I.O. Klimenko. Renal cell carcinoma: contemporary diagnostics and therapeutic approach // Journal of general practitioner.-2000.-V.6.-P. 22-24.
I.O. Klimenko, V.S. Sakalo, V.M. Grigorenko et al. Immunochemotherapy of renal cell carcinoma // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and applied aspects”, 22-23 May 2003, Kiev.-P.157.
S.I. Korovin, V.E. Zhylchuk, T.E. Tkachuk et. al. The experience of administration of home-manufactured recombinant alpha-2b inerferon – Laferon in oncologic clinical use // Pharmaceutical journal.–1998.–V.1.–P. 66-70.
V.E. Zhylchuk, Recombinant alpha-2b interferon (laferon) in treatment of patients with advanced ovarian cancer. – Manuscript // Dissertation for the scientific degree of candidate of medical sciences.-Kyiv.-1998.
V.E. Zhilchuk. Efficiency of laferon therapy in the treatment of patients with extended cancer of the ovary // Medical business.–1998.–V.3.–P. 117-119.
V.Ye. Zhilchuk, A.V. Alistratov, A.L. Vorontsova. Adjuvant laferon therapy in a combined treatment of patients with ovarian carcinoma: assessment of efficiency in the monitoring of the tumor marker CA- 125 in blood serum// Medical business. -1998.-V. 2.-P.137-139.
V.E. Zhilchuk, A.L. Vorontsova. Interferon in complex treatment of patients with locally invasive mammary gland cancer // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and practical aspects”, 22-23 May 2003, Kiev.-P.155.
A.L. Vorontsova, Yu.I. Kudryavets. Interferon as an important element of oncological patients’ therapy. // Oncology.–2000.–V.2, Issue 1-2.–P. 16-20.
U.I. Kudriavets. Investigation of some mechanism of synergistic interferon and tumor necrosis factor action in cell cultures of human malignant neoplasm // Pharmaceutical journal.-1998.-V.6.-P.74-78.
Yu.A. Grinevich, F.V. Filchakov, V.L. Ganul, I.I. Smolanka. Adoptive immunotherapy in surgical treatment of lung cancer patients // Oncology.–2000.–V.2, Issue 1-2.–P. 68-71.
I.B. Shchepotin, K.A. Galakhin, Ye.G. Kurik. The outlook for the treatment of the carcinoma of the stomach. // Medical business.-2002-V.1.-P.3-8.
G.I Macsimyak, G.U. Smirnov, U.V. Chishkevich et al. Long-term results of complex treatment by means of cytokines in patients with rectal cancer // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and practical aspects”, 22-23 May 2003, Kiev.-P. 159-160.
N.N. Tretiak, M.V. Bondar, A.I. Koval et al. The use of laferon, a home medicine preparation, in a multimodality treatment of patients with chronic myeloid leukemia. // Medical business.–1999.–V.5.–P.131-134.
Al.I. Gordienko, L.M. Isakova, N.N. Tretiak et al. Immunological monitoring of patients with chronic myeloleukemia at the stage of clinico-hematological compensation at the background of immunomodulating therapy // Immunology and allergology.-1998.-V.3.-P.44-47.
A.F. Romanova. Chronic myelogenous leukemia, clinic, differential diagnostics, treatment // Journal of general practitioner.-2000.-V.2.-P.16-19.
Information letter of MHU Ukraine . Method of complex multiple myeloma treatment with the use of domestically produced drug Laferon. V.88-97.-Kiev.
Information letter of MHU Ukraine. The use of Laferon in complex treatment programs of chronic myeloleukemia. V.89-97.-Kiev.
N.M. Tretiak, V.M. Minishenko. Chronic myeloid leukemia – clinical characteristic and therapeutic tactics // Medicines.-2002.-V.3-4.-P.7-12.
S. Gaidukova, O. Karnabeda. The use of recombinant interferon alpha-2b in complex therapy of T-cell skin lymphoma // Medicines of Ukraine.-2002.-V.10.-P.40-41.
N.M. Tretiak, R.P. Pavluk, O.V. Basova, I.Yu. Slavchenko. Dynamics of cell-mediated and humoral immunity indices in patients with idiopathic myelofibrosis which where treated using interferon alpha-2b // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and practical aspects”, 22-23 May 2003, Kiev.-P.170.
N.M. Tretiak, R.P. Pavluk, V.M. Mnishenko. Analysis of dynamics indices of cell-mediated and humoral immunity in patients with polycythemia treated with interferon alpha-2b // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and practical aspects”, 22-23 May 2003, Kiev.- P. 169.
V.M. Semenova, N.I. Lisyanii, V.D. Rozumenko, L.P. Staino. Evaluation of glial brain tumour sensitivity to influence of interferon alpha-2b in cytotoxic test. // Oncology.-2003.-V.5, Issue 2. // Materials of research and practical conference “Problems of oncoimmunology: scientific and practical aspects”, 22-23 May 2003, Kiev.- P.140.

T.A. Kobys. Efficiency laferon use for treatment of patients with multiple sclerosis // Bulletin of pharmacology.–1998.–V.4.–P. 54-55.
S.M. Vinichuk, T.O. Kobys. Relative evaluation therapeutic efficiency of untraditional and traditional therapy methods of multiple sclerosis // Journal of general practitioner.-2000.-V.3.-P.8-11.
L.I. Sokolova. Modern approaches to pharmacotherapy of disseminated multiple sclerosis // Journal of general practitioner.-1998.-V.6.-P.38-40.

A.I.Golovchenko. Results of chronic gastritis treatment by means of immunocorrection therapy // Gastrenterology, interdepartmental edition.–1999.–V.29.–P. 32-34.

I.V. Putinzeva. Comparative efficiency of interferon and interferon-synthesis inducer amizon in treatment of multiple peptic ulcers patients // Scientific work materials of republic practical-scientific conference. "Achievements and unsolved problems of gastroenterology" 7-8 April 1998.– Kharkov.–1998.–P. 158.
I.V. Putinceva. Comparative efficiency of interferon and inductor of interferon production – amizone in treatment of patients with multiple peptic ulcer // Ukrainian chemotherapeutical journal.–2000.–V.1 (5).–P. 46-50.

S.P. Khodakivska. Specialty of cells and humoral immunity in patients with chronical diseases of gallbladder tract with laferon course therapy // Pediatrics, obstetrics and gynecology.–1997.–V.6.–P. 34-38.
Information letter of Health Protection Department of Odessa ’s regional state administration. Sepsis – difficulties of diagnostic and possibilities of treatment. № 786/02 of 29.05.98 Odessa .
S.P Hodakivska. Characteristics of cell-mediated and humoral immunity in children with chronic diseases of bile-excreting system at complex Laferon treatment // Pediatry, obstetrics and gynecology.–1997.–V.6.–P. 34-38.
A.F. Frolov, V.M. Frolov, I.V. Loskutova et al. Up-to-date treatment of varicella // Bulletin of pharmacology-2000.-V.4.-P.18-22.
O.F. Vozianov, G.M. Drannik, V.Ye. Driyanska et al. Clinico-immunologic effects of Laferon in patients with chronic urogenital chlamidiosis // Urology.-2001.-V.3.-P. 38-42.
Information letter of MHU Ukraine . Method of chronic urogenital clamidiosis treatment by means of Laferon. V.97-2001.-Kiev.
G.M. Dranik, G.V. Fedoruk, R.E. Suhin et al. Method of chronic urogenital clamidiosis treatment // Patent for invention 34873 А.
B.S. Zaporozhchenko, I.E. Borodayev. Thiol-sulphate system state in acute pancreatitis patients under the conditions of laparoscopic sanation and interferon administration.-Bulletin of sea medicine.-2000.-V.3, P.11.
M.S. Zolotuhin, O.G. Linichevskii. Influence of Laferon on changes in indices of lipid peroxidation and antioxidant defence under the threat of premature birth // Pediatry, obstetrics and gynecology.-2000.-V.3.-P. 94-96.
G.I. Dorozhina. Viral diseases of cornea and conjunctiva // Health of Ukraine.-2002.-V.5.-P. 26-28.

V.P. Vinogradov, A.T. Slabospitskaya, V.A. Kordum. Laferon in treatment of newborns // Materials of scientific and practical conference “Laferon in treatment of infection and oncologic diseases”.– Rovno.–1996.–P.24-31.
E. Shunko, O. Laksha, L. Krivohatska. Pathogenic substantiation of Laferon therapy in newborn with hepatitis B // Medicines of Ukraine.–2000.–V.7-8.–P.49-51.
A.B. Volosnianko. Time-related changes in indices of humoral immunity and beta2-microglobulin content in children with chronic hepatitis // Medical business.–2000.–V.2.–P.67-69.
S.A. Kramarev. Modern approaches to virus hepatitis treatment in children // Health of Ukraine.-2003.-V.18 (79).-P.16.
S.P. Hodakivska. Characteristics of cell-mediated and humoral immunity in children with chronic diseases of bile-excreting system at complex Laferon treatment // Pediatry, obstetrics and gynecology.–1997.–V.6.–P. 34-38.
O.M. Lukianova. Peculiarities, diagnostics and treatment of the most widespread diseases in children, which suffered in accident on CAPS // Treatment and diagnostics.-1996.-V.2.-P.6-10.
O. Lukianova, O. Konovalchuk, M. Spivak. Interferon status indices in children with acute and residual bronchopulmonary pathology and the use of recombinant alpha-2b interferon (Laferon) in complex therapy // Medicines of Ukraine.-2001.-V.1.-P.59-60.
L.P. Shostakovich-Koretska, O.L. Krivusha. Laferon in treatment of acute enteric infection (AEI) and intestines disbacteriosis in children // V scientific and practical conference “Urgent questions of allergology, clinical and laboratory immunology”, 20-22 November 2000. Immunology and allergology.-2000.-V.2-3.-P.72.
L.P. Shostakovich-Koretska, O.L. Krivusha. Laferon treatment of rotavirus diarrhea in children // Reports of І All-Ukrainian scientific and practical conference concerning immunology and pediatry questions.- Perinatology and pediatry.-2001.-V.3.-P.105.
L.P. Shostakovich-Koretska, O.L. Krivusha., I.O. Girina. Effectiveness of Laferon application in children with acute enteric infections of bacterial and viral etiology // Materials of second research and practical conference “Antibacterial, anti-inflammatory and immunoactive therapy in pediatry”, Kiev , 17-18 April 2001.-Pediatry, obstetrics and gynecology.-2001.-V.4.-P. 75-76.

V.P. Miroshnychenko, G.F. Ponomarenko, N.Ya. Dotsenko. Interferons and their inductors: theoretical and clinical aspects of application // Laboratory diagnostics. - 2002. – V.4, P. 70-76.